Tofacitinib Is the Right OCTAVE for Ulcerative Colitis

Posted on July 28, 2017 by Gastroenterology Journal

Sandborn W, Su C, Sands BE, et al. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med 2017;376:2017;1723-1736.

This entry was posted in News. Bookmark the permalink.